PROTAGONIST THERAPEUTICS - Trademark Details
Status: 700 - Registered
Image for trademark with serial number 88450820
Serial Number
88450820
Registration Number
6142951
Word Mark
PROTAGONIST THERAPEUTICS
Status
700 - Registered
Status Date
2020-09-01
Filing Date
2019-05-29
Registration Number
6142951
Registration Date
2020-09-01
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) Typeset
Design Searches
260129 - Helixes.
Published for Opposition Date
2019-12-17
Attorney Name
Lawrence D. Mandel
Law Office Assigned Location Code
M40
Employee Name
MURRAY, DAVID T
Statements
Certificate of Correction for Registration
In the statement, line 1, "CALIFORNIA" should be deleted, and "DELAWARE" should be inserted.
Indication of Colors claimed
The color(s) black and orange is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text
"THERAPEUTICS"
Description of Mark
The mark consists of the word "Protagonist" in black above the word "Therapeutics" in orange to the right of the words is a DNA double helix in the colors black and orange. The entire mark is on a transparent background.
Goods and Services
SCIENTIFIC RESEARCH, PHARMACEUTICAL RESEARCH, MEDICAL RESEARCH; TECHNICAL AND SCIENTIFIC CONSULTATION AND PRODUCT DEVELOPMENT SERVICES FOR OTHERS, IN THE FIELD OF IMMUNE MEDIATED DISEASES, INFLAMMATORY DISEASES, AND RARE DISEASES; RESEARCH AND DEVELOPMENT OF NEW PRODUCTS PERTAINING TO THE TREATMENT OF IMMUNE MEDIATED DISEASES, INFLAMMATORY DISEASES, AND RARE DISEASES, AND TO PHARMACEUTICALS; PROVIDING ON-LINE INFORMATION FOR MEDICAL RESEARCH PURPOSES, IN THE FIELDS OF IMMUNE MEDIATED DISEASES, INFLAMMATORY DISEASES, AND RARE DISEASES, TREATMENTS FOR IMMUNE MEDIATED DISEASES, INFLAMMATORY DISEASES, AND RARE DISEASES, AND PHARMACEUTICALS
Classification Information
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2019-06-13
Primary Code
042
First Use Anywhere Date
2016-05-10
First Use In Commerce Date
2016-05-10
Current Trademark Owners
Party Name
Protagonist Therapeutics, Inc.
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Protagonist Therapeutics, Inc.
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Protagonist Therapeutics, Inc.
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Protagonist Therapeutics, Inc.
Party Type
10 - Original Applicant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Lawrence D. Mandel
Address
Please log in with your Justia account to see this address.
Trademark Events
Event DateEvent Description
2019-06-01NEW APPLICATION ENTERED IN TRAM
2019-06-13NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2019-06-14NOTICE OF DESIGN SEARCH CODE E-MAILED
2019-08-19ASSIGNED TO EXAMINER
2019-08-21PRIORITY ACTION WRITTEN
2019-08-21PRIORITY ACTION E-MAILED
2019-08-21NOTIFICATION OF PRIORITY ACTION E-MAILED
2019-11-05TEAS RESPONSE TO OFFICE ACTION RECEIVED
2019-11-05CORRESPONDENCE RECEIVED IN LAW OFFICE
2019-11-06TEAS/EMAIL CORRESPONDENCE ENTERED
2019-11-06APPROVED FOR PUB - PRINCIPAL REGISTER
2019-11-12ASSIGNED TO LIE
2019-11-27NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2019-12-17PUBLISHED FOR OPPOSITION
2019-12-17OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2020-02-11NOA E-MAILED - SOU REQUIRED FROM APPLICANT
2020-07-02TEAS STATEMENT OF USE RECEIVED
2020-07-23CASE ASSIGNED TO INTENT TO USE PARALEGAL
2020-07-02USE AMENDMENT FILED
2020-07-23STATEMENT OF USE PROCESSING COMPLETE
2020-07-24ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
2020-07-25NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
2020-09-01REGISTERED-PRINCIPAL REGISTER
2021-03-11TEAS SECTION 7 REQUEST RECEIVED
2021-07-06CASE ASSIGNED TO POST REGISTRATION PARALEGAL
2021-07-06POST REGISTRATION ACTION MAILED - SEC. 7
2021-07-06POST REGISTRATION ACTION MAILED - SEC. 7
2021-07-07POST REGISTRATION ACTION MAILED - SEC. 7
2021-09-16TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
2021-03-11SEC 7 REQUEST FILED
2021-09-17CORRECTION UNDER SECTION 7 ¿ PROCESSED